Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernanda Maruri

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
International Journal of Antimicrobial Agents|June 29, 2013
Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolonesYuri F van der Heijden, Fernanda Maruri, Amondrea Blackman, et al.
The Journal of Antimicrobial Chemotherapy|December 28, 2020
Re-evaluation of a novel resistance mutation in eccC5 of the ESX-5 secretion system in ofloxacin-resistant Mycobacterium tuberculosisAmondrea Blackman, Bob Morrison, Fernanda Maruri, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2009
Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposureRose A Devasia, Amondrea Blackman, Tebeb Gebretsadik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2020
Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV)April C Pettit, Jason E Stout, Robert Belknap, et al.
Studies in Health Technology and Informatics|May 17, 2025
A Customizable Data Quality Tool for Global Observational Research NetworksJudith Lewis, Brenna Hogan, Charles Goss, et al.
Journal of Clinical Microbiology|December 23, 2011
High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibilityRose Devasia, Amondrea Blackman, Svetlana Eden, et al.
Frontiers in Immunology|June 14, 2023
Failure to decrease HbA1c levels following TB treatment is associated with elevated Th1/Th17 CD4+ responsesRobert Krause, Christian M Warren, Joshua D Simmons, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 23, 2023
Cryptococcal Meningitis and Clinical Outcomes in Persons With Human Immunodeficiency Virus: A Global ViewAnna K Person, Brenda Crabtree-Ramirez, Ahra Kim, et al.
Journal of the International AIDS Society|October 7, 2024
Prevalence and co-occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low- and middle-income countries: a cross-sectional studyAngela M Parcesepe, Melissa Stockton, Charlotte Bernard, et al.
Frontiers in Immunology|September 28, 2020
Increased Neutrophil Count and Decreased Neutrophil CD15 Expression Correlate With TB Disease Severity and Treatment Response Irrespective of HIV Co-infectionLerato N Ndlovu, Lauren Peetluk, Sashen Moodley, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Antimicrobial Agents|June 29, 2013
Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolonesYuri F van der Heijden, Fernanda Maruri, Amondrea Blackman, et al.
The Journal of Antimicrobial Chemotherapy|December 28, 2020
Re-evaluation of a novel resistance mutation in eccC5 of the ESX-5 secretion system in ofloxacin-resistant Mycobacterium tuberculosisAmondrea Blackman, Bob Morrison, Fernanda Maruri, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2009
Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposureRose A Devasia, Amondrea Blackman, Tebeb Gebretsadik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 8, 2020
Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV)April C Pettit, Jason E Stout, Robert Belknap, et al.
Studies in Health Technology and Informatics|May 17, 2025
A Customizable Data Quality Tool for Global Observational Research NetworksJudith Lewis, Brenna Hogan, Charles Goss, et al.
Journal of Clinical Microbiology|December 23, 2011
High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibilityRose Devasia, Amondrea Blackman, Svetlana Eden, et al.
Frontiers in Immunology|June 14, 2023
Failure to decrease HbA1c levels following TB treatment is associated with elevated Th1/Th17 CD4+ responsesRobert Krause, Christian M Warren, Joshua D Simmons, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 23, 2023
Cryptococcal Meningitis and Clinical Outcomes in Persons With Human Immunodeficiency Virus: A Global ViewAnna K Person, Brenda Crabtree-Ramirez, Ahra Kim, et al.
Journal of the International AIDS Society|October 7, 2024
Prevalence and co-occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low- and middle-income countries: a cross-sectional studyAngela M Parcesepe, Melissa Stockton, Charlotte Bernard, et al.
Frontiers in Immunology|September 28, 2020
Increased Neutrophil Count and Decreased Neutrophil CD15 Expression Correlate With TB Disease Severity and Treatment Response Irrespective of HIV Co-infectionLerato N Ndlovu, Lauren Peetluk, Sashen Moodley, et al.
Pageof 5